GlassScriptPhysician profile
Brielle Maser
NPI 1700352549
$3,882.21
in general payments reported to CMS, 2019-2025
20 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,131 · 2023: $535 · 2024: $838 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724 · Travel and Lodging: $26.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,723.78 |
| Travel and Lodging | $26.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $722.86 | 2025 | Rapiblyk |
| Boehringer Ingelheim Pharmaceuticals, INC. | $688.92 | 2022-2025 | Jardiance |
| Amgen INC. | $389.61 | 2022-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $351.28 | 2022-2024 | Leqvio |
| Janssen Pharmaceuticals, INC | $322.67 | 2022-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $267.71 | 2022-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $235.21 | 2022-2025 | Watchman Flx, Ams 700 |
| Atricure, INC. | $173.42 | 2024 | |
| Pfizer INC. | $138.14 | 2022 | |
| Bridgebio Pharma, INC. | $113.84 | 2025 | Attruby |
| Novo Nordisk INC | $94.50 | 2022-2024 | Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $65.79 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $65.76 | 2025 | |
| Alnylam Pharmaceuticals INC. | $54.40 | 2023-2025 | Onpattro |
| Medtronic, INC. | $53.52 | 2022-2025 | Azure Xt Dr Mri Surescan |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $40.77 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Impulse Dynamics (USA) INC. | $38.10 | 2024 | Optimizer |
| Astellas Pharma US INC | $23.84 | 2022 | |
| Heartflow, INC. | $21.88 | 2025 | |
| Terumo Medical Corporation | $19.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brielle Maser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.